Artal Group’s bluebird bio BLUE Stock Holding History

Artal Group’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-7,720	Closed	-$9.92M	–	107
2018 Q4	$9.92M	Buy	+7,720	New	+$11.8M	0.37%	44
2018 Q3	–	Sell	-3,860	Closed	-$7.85M	–	107
2018 Q2	$7.85M	Buy	+3,860	New	+$8.8M	0.17%	54
2018 Q1	–	Sell	-3,860	Closed	-$8.9M	–	116
2017 Q4	$8.9M	Hold	3,860	–	–	0.13%	48
2017 Q3	$6.87M	Hold	3,860	–	–	0.12%	54
2017 Q2	$5.25M	Buy	+3,860	New	+$4.66M	0.09%	58
2017 Q1	–	Sell	-7,720	Closed	-$6.17M	–	99
2016 Q4	$6.17M	Buy	7,720 +3,860	+100%	+$3.07M	0.14%	50
2016 Q3	$3.39M	Sell	3,860 -3,860	-50%	-$2.8M	0.07%	73
2016 Q2	$4.33M	Buy	+7,720	New	+$4.37M	0.09%	43
2016 Q1	–	Sell	-3,860	Closed	-$3.21M	–	62
2015 Q4	$3.21M	Hold	3,860	–	–	0.06%	70
2015 Q3	$4.28M	Buy	+3,860	New	+$7.04M	0.1%	57
2015 Q1	–	Sell	-7,720	Closed	-$9.17M	–	76
2014 Q4	$9.17M	Buy	+7,720	New	+$5.16M	0.32%	50

Other funds holding BLUE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artal Group's BLUE Position: Q2 2020 in Review

Artal Group sold out of bluebird bio (BLUE) in Q2 2020, closing a stake of 7,720 shares — an estimated $4.6M sold.

Artal Group first reported a position in BLUE in Q3 2013 and held it in 27 quarters. The position peaked at $42.3M in Q1 2015. 278 funds tracked by Wall St. Rank hold BLUE as of Q2 2020.

Artal Group reported no remaining bluebird bio position as of Q2 2020 after selling out during the quarter.
Artal Group sold 7,720 bluebird bio shares in Q2 2020, an estimated $4.6M.
Artal Group first reported a position in bluebird bio in Q3 2013 and held it in 27 quarters.
Artal Group's bluebird bio position peaked at $42.3M in Q1 2015.
278 funds tracked by Wall St. Rank held bluebird bio as of Q2 2020.

Based on Artal Group's 13F filing for Q2 2020, filed 14 Aug 2020.